Livagen vs Ovagen
Moderate Research vs Moderate Research
synergistic Complementary liver bioregulators with different sequences.
Molecular Data
Livagen Ovagen
Weight 432 Da 375 Da
Half-life Not established Not established
Chain 4 amino acids 3 amino acids
Type Tetrapeptide bioregulator Tripeptide bioregulator
Key Benefits
Livagen
01 Significant hepatoprotective properties
02 Decondenses chromatin to activate genes
03 Restores liver function in hepatitis
04 Normalizes immune status
05 Improves antioxidant status
06 Activates ribosomal gene expression
07 Maximum effects occur during aging
08 Boosts protein synthesis and cell activity
Ovagen
01 Reduces long-term liver fibrosis
02 Protects GI mucosal layer
03 Defense against antibiotic damage
04 Protection from environmental toxins
05 May protect against chemotherapy GI effects
06 Tissue-specific targeting via PEPT transporters
07 Direct DNA regulation
08 Part of comprehensive anti-aging protocols
Dosing Protocols
Livagen
10-20 mg daily / Daily for 10-20 days per cycle
Research protocol 10 mg Daily for 10 days
Ovagen
10-20mg daily / Daily for 10-20 days per cycle
Research protocol 10 mg Daily for 10 days
Side Effects
Livagen
Generally well-tolerated
Minimal side effects reported
Ovagen
Generally well-tolerated
Minimal side effects reported
Contraindications
Active liver emergencies (seek medical care)
Known hypersensitivity
Pregnancy or breastfeeding
Active liver emergencies (seek medical care)
Known hypersensitivity
Pregnancy or breastfeeding
Research Evidence
Livagen Ovagen
Status Moderate Research Moderate Research
References 4 studies 3 studies
FDA Approved No No
This comparison is for educational and research purposes only. Consult a healthcare professional before use.